CoChat

The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation

Open access

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Abstract

Clostridioides difficile infection (CDI) is the leading cause of postantibiotic nosocomial infection. Antibiotic therapy can be successful, yet up to one-third of individuals suffer from recurrent infections. Understanding the mechanisms controlling C. difficile colonization is paramount in designing novel treatments for primary and recurrent CDI. Here, we found that limiting nutrients control C. difficile metabolism during CDI and influence overall pathogen fitness. Specifically, the immune protein CP limits Zn availability and increases transcription of C. difficile genes necessary for proline fermentation. Paradoxically, this leads to reduced C. difficile proline fermentation. This reduced fermentation is due to limited availability of another nutrient required for proline fermentation, Se. Therefore, CP-mediated Zn limitation combined with low Se levels overall reduce C. difficile fitness in the intestines. These results emphasize the complexities of how nutrient availability influences C. difficile colonization and provide insight into critical metabolic processes that drive the pathogen’s growth.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mbio.02289-19

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG 1 C. difficile alters gene transcription in response to CP treatment and infection. (A) Combined RNA-seq and Nanostring results showing global changes in C. difficile gene expression in response to CP in medium and significantly different changes in gene expression during infection compared to that in medium, respectively. (i and ii) Sense and antisense genes, respectively, in C. difficile strain R20291. (iii and iv) Each bar represents a gene significantly upregulated or downregulated, respectively, in medium containing calprotectin compared to that in medium alone. Each level of color gradation represents a 2.5-fold change. Genes with expression > or <7.5-fold change are represented with bars that hit the maximum limit. (v) Green bars show phage genes present in RNA-seq. (vi and vii) Each bar represents genes from Nanostring panel with significantly upregulated or downregulated expression, respectively, during infection relative to expression in medium. (B) Genes identified in the RNA-seq analysis with significantly different expression grouped into predicted functional categories. (C) Log2 fold change of genes from the Nanostring panel significantly upregulated or downregulated during infection compared to expression in medium. #, genes similarly upregulated or downregulated in RNA-seq and Nanostring panel; ^, gene with expression found to be significantly upregulated according to RNA-seq in response to calprotectin but significantly downregulated according to Nanostring during infection.
FIG 1 C. difficile alters gene transcription in response to CP treatment and infection. (A) Combined RNA-seq and Nanostring results showing global changes in C. difficile gene expression in response to CP in medium and significantly different changes in gene expression during infection compared to that in medium, respectively. (i and ii) Sense and antisense genes, respectively, in C. difficile strain R20291. (iii and iv) Each bar represents a gene significantly upregulated or downregulated, respectively, in medium containing calprotectin compared to that in medium alone. Each level of color gradation represents a 2.5-fold change. Genes with expression > or <7.5-fold change are represented with bars that hit the maximum limit. (v) Green bars show phage genes present in RNA-seq. (vi and vii) Each bar represents genes from Nanostring panel with significantly upregulated or downregulated expression, respectively, during infection relative to expression in medium. (B) Genes identified in the RNA-seq analysis with significantly different expression grouped into predicted functional categories. (C) Log2 fold change of genes from the Nanostring panel significantly upregulated or downregulated during infection compared to expression in medium. #, genes similarly upregulated or downregulated in RNA-seq and Nanostring panel; ^, gene with expression found to be significantly upregulated according to RNA-seq in response to calprotectin but significantly downregulated according to Nanostring during infection.CC BY · PubMed Central
FIG 2 Calprotectin-mediated Zn limitation leads to increased expression of proline fermentation genes. (A) Relative prdA expression normalized to rpoB via qPCR in TY medium with or without 30 mM l-proline, 42 μM or 150 μM ZnCl2, 42 μM MnCl2, calprotectin site I mutant (CP ΔSI), or site I and site II (CP ΔSI/SII) mutant. (B) Relative prdA expression normalized to rpoB via qPCR in TY medium with or without 30 mM l-proline, 75 μM TPEN, or 75 μM ZnCl2. *, P < 0.05 one-way ANOVA followed by Tukey’s multiple-comparison test; ns, not significant.
FIG 2 Calprotectin-mediated Zn limitation leads to increased expression of proline fermentation genes. (A) Relative prdA expression normalized to rpoB via qPCR in TY medium with or without 30 mM l-proline, 42 μM or 150 μM ZnCl2, 42 μM MnCl2, calprotectin site I mutant (CP ΔSI), or site I and site II (CP ΔSI/SII) mutant. (B) Relative prdA expression normalized to rpoB via qPCR in TY medium with or without 30 mM l-proline, 75 μM TPEN, or 75 μM ZnCl2. *, P < 0.05 one-way ANOVA followed by Tukey’s multiple-comparison test; ns, not significant.CC BY · PubMed Central
FIG 3 Proline fermentation contributes to C. difficile growth in vitro. (A) Genes involved in proline fermentation. Dark triangles indicate location of intron insertion using ClosTron mutagenesis. Arrow indicates the location of the selenocysteine codon in the gene of the main catalytic subunit for the proline reductase, prdB. (B) Growth of WT, prdB::CT, and prdR::CT strains in TY medium containing 30 mM l-proline as measured by OD600. (C) 5-Aminovalerate concentrations in spent media of WT C. difficile, prdB::CT, and prdR::CT strains. Error bars indicate standard deviations. nd, not detected; *, P < 0.05 between WT and prdB::CT at indicated time point; **, P < 0.05 between WT and prdR::CT at indicated time point by two-way ANOVA and Dunnett’s multiple comparisons.
FIG 3 Proline fermentation contributes to C. difficile growth in vitro. (A) Genes involved in proline fermentation. Dark triangles indicate location of intron insertion using ClosTron mutagenesis. Arrow indicates the location of the selenocysteine codon in the gene of the main catalytic subunit for the proline reductase, prdB. (B) Growth of WT, prdB::CT, and prdR::CT strains in TY medium containing 30 mM l-proline as measured by OD600. (C) 5-Aminovalerate concentrations in spent media of WT C. difficile, prdB::CT, and prdR::CT strains. Error bars indicate standard deviations. nd, not detected; *, P < 0.05 between WT and prdB::CT at indicated time point; **, P < 0.05 between WT and prdR::CT at indicated time point by two-way ANOVA and Dunnett’s multiple comparisons.CC BY · PubMed Central
FIG 4 Proline fermentation contributes to C. difficile growth during primary and relapse infection. (A) Model of antibiotic-induced CDI and relapse. (B and C) C. difficile abundances in the feces of mice coinfected with WT C. difficile and the prdB::CT or prdR::CT mutant, respectively. Each dot represents CFU from an individual mouse. Shaded boxes represent the times when mice were provided vancomycin to induce relapse. Bars represent geometric means. (D and E) The competitive indices (CIs) (input/output ratios) of WT to mutant C. difficile in mice included in data shown in panels B and C. Each dot represents the CI for an individual mouse. Bars represent the geometric means. (F) 5-Aminovalerate concentrations in the feces of naive mice, mice provided cefoperazone treatment only, or mice provided cefoperazone treatment and subsequently infected with either WT C. difficile or the prdB::CT mutant. *, P < 0.05 by unpaired t test.
FIG 4 Proline fermentation contributes to C. difficile growth during primary and relapse infection. (A) Model of antibiotic-induced CDI and relapse. (B and C) C. difficile abundances in the feces of mice coinfected with WT C. difficile and the prdB::CT or prdR::CT mutant, respectively. Each dot represents CFU from an individual mouse. Shaded boxes represent the times when mice were provided vancomycin to induce relapse. Bars represent geometric means. (D and E) The competitive indices (CIs) (input/output ratios) of WT to mutant C. difficile in mice included in data shown in panels B and C. Each dot represents the CI for an individual mouse. Bars represent the geometric means. (F) 5-Aminovalerate concentrations in the feces of naive mice, mice provided cefoperazone treatment only, or mice provided cefoperazone treatment and subsequently infected with either WT C. difficile or the prdB::CT mutant. *, P < 0.05 by unpaired t test.CC BY · PubMed Central
FIG 5 Se and Zn limitation decrease C. difficile proline fermentation. (A) 5-Aminovalerate concentrations in spent medium of C. difficile grown in the presence of 75 μM TPEN. TY was supplemented with l-proline (30 mM final concentration). Each dot represents a single replicate. Bacteria were grown to early exponential phase (OD600 of ∼0.2) (B) The intracellular NAD+/NADH ratios of WT or prdB::CT C. difficile grown in TY medium with or without 75 μM TPEN or 75 μM ZnCl2. (C) Intracellular selenium abundance in C. difficile grown in TY medium with or without 75 μM TPEN or 10 μM Na2SeO3 determined through ICP-MS. (D) 5-Aminovalerate concentrations in spent medium from C. difficile grown in TY medium with or without 75 μM TPEN, 10 μM Na2SeO3, or 75 μM ZnCl2 at the indicated time points. Error bars indicate standard deviations. (E) PrdB peptide (TAVIVQR) abundance relative to abundance of an SlpA S-layer peptide (LYNLVNTQLDK). The PrdB peptide is downstream of the selenocysteine residue. Data represent 2 to 3 replicates. Error bars indicate standard deviations. *, P < 0.05 by unpaired t test.
FIG 5 Se and Zn limitation decrease C. difficile proline fermentation. (A) 5-Aminovalerate concentrations in spent medium of C. difficile grown in the presence of 75 μM TPEN. TY was supplemented with l-proline (30 mM final concentration). Each dot represents a single replicate. Bacteria were grown to early exponential phase (OD600 of ∼0.2) (B) The intracellular NAD+/NADH ratios of WT or prdB::CT C. difficile grown in TY medium with or without 75 μM TPEN or 75 μM ZnCl2. (C) Intracellular selenium abundance in C. difficile grown in TY medium with or without 75 μM TPEN or 10 μM Na2SeO3 determined through ICP-MS. (D) 5-Aminovalerate concentrations in spent medium from C. difficile grown in TY medium with or without 75 μM TPEN, 10 μM Na2SeO3, or 75 μM ZnCl2 at the indicated time points. Error bars indicate standard deviations. (E) PrdB peptide (TAVIVQR) abundance relative to abundance of an SlpA S-layer peptide (LYNLVNTQLDK). The PrdB peptide is downstream of the selenocysteine residue. Data represent 2 to 3 replicates. Error bars indicate standard deviations. *, P < 0.05 by unpaired t test.CC BY · PubMed Central
FIG 6 Calprotectin restricts C. difficile proline fermentation during infection. (A) Abundance of Zn and Se in the feces of WT C57BL/6 or S100A9−/− mice infected with WT C. difficile. Box plots represent the median, maximum, and minimum values; N = 8 to 10 mice per time point per genotype. (B) C. difficile abundance in coinfected mice at day 2 postinfection. Each dot represents CFU from a single mouse. *, P < 0.05, ln-transformed data. (C) The competitive indices of WT C57BL/6 and S100A9−/− mice coinfected with WT and prdB::CT C. difficile included in the data shown in panel B. *, P < 0.05 by unpaired t test; error bars represent the standard errors of the means.
FIG 6 Calprotectin restricts C. difficile proline fermentation during infection. (A) Abundance of Zn and Se in the feces of WT C57BL/6 or S100A9−/− mice infected with WT C. difficile. Box plots represent the median, maximum, and minimum values; N = 8 to 10 mice per time point per genotype. (B) C. difficile abundance in coinfected mice at day 2 postinfection. Each dot represents CFU from a single mouse. *, P < 0.05, ln-transformed data. (C) The competitive indices of WT C57BL/6 and S100A9−/− mice coinfected with WT and prdB::CT C. difficile included in the data shown in panel B. *, P < 0.05 by unpaired t test; error bars represent the standard errors of the means.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 71 references

Cited by

See all 42

Metadata

Authors
Lopez, C. A., Beavers, W. N., Weiss, A., Knippel, R. J., Zackular, J. P., Chazin, W., & Skaar, E. P.
Affiliations
  • Vanderbilt University (US)
  • Children's Hospital of Philadelphia (US)
Corresponding author
Skaar, Eric P.
Venue
mBio
Published
2019-12-24
Volume
10
Issue
6
ISSN
  • 2150-7511 (ISSN-L)
  • 2161-2129
OpenAlex
W2987746896
Cited by
42
References
71
Citations by year
2026: 4 · 2025: 8 · 2024: 2 · 2023: 11 · 2022: 7 · 2021: 6 · 2020: 4
FWCI
3.26
Type
journal article
Language
en
Open access
Licence
Locations
  • mBio (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • National Institute of General Medical Sciences (AI118089)
  • HHS | NIH | National Institute of Allergy and Infectious Diseases (T32AI095202, T32AI007281, F32AI120553, K22AI37220)
  • HHS | NIH | National Institute of General Medical Sciences (T32GM065086)
  • HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK058404)
  • American Heart Association
  • Burroughs Wellcome Fund
  • Jane Coffin Childs Memorial Fund for Medical Research
Topics
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
calprotectin, Clostridium difficile, zinc limitation, selenium, nutrient limitation, bacterial metabolism, recurrent Clostridium difficile infection, immune proteins, bacterial colonization, pathogen fitness
MeSH terms
Clostridium Infections, Energy Metabolism, Fermentation, Proline, Zinc, Gene Expression Regulation, Bacterial, Clostridioides difficile, Leukocyte L1 Antigen Complex

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation. https://app.cochat.ai/papers/10.1128/mbio.02289-19
The paper
Lopez, C. A., Beavers, W. N., Weiss, A., Knippel, R. J., Zackular, J. P., Chazin, W., & Skaar, E. P. (2019). The Immune Protein Calprotectin Impacts Clostridioides difficile Metabolism through Zinc Limitation. mBio. https://doi.org/10.1128/mbio.02289-19

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.